Search
Results: 2
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC)
Alberto D'Angelo, Stefan Bagby, Giulia Di Pierro, Martina Chirra, Stefania Nobili, Enrico Mini, Donata Villari, Giandomenico Roviello
May 31, 2020
Patients diagnosed with non-clear renal cell carcinoma have often been excluded from clinical trials due to the shortage of treatments available, the low incidence of tumours with non-clear histology, and the corresponding...
Anilides/therapeutic use Antibodies Monoclonal/therapeutic use Antineoplastic Agents/therapeutic use Carcinoma Renal Cell/drug therapy Disease-Free Survival Humans Kidney Neoplasms/drug therapy Protein Kinase Inhibitors Pyridines/therapeutic use /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being name=SDG 3 - Good Health and Well-being
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC)
Alberto D'Angelo, Stefan Bagby, Giulia Di Pierro, Martina Chirra, Stefania Nobili, Enrico Mini, Donata Villari, Giandomenico Roviello
May 31, 2020
Patients diagnosed with non-clear renal cell carcinoma have often been excluded from clinical trials due to the shortage of treatments available, the low incidence of tumours with non-clear histology, and the corresponding...
Anilides/therapeutic use Antibodies Monoclonal/therapeutic use Antineoplastic Agents/therapeutic use Carcinoma Renal Cell/drug therapy Disease-Free Survival Humans Kidney Neoplasms/drug therapy Protein Kinase Inhibitors Pyridines/therapeutic use /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being name=SDG 3 - Good Health and Well-being